Related Experiment Video
Updated: Jun 26, 2025

Assessment of Selective mRNA Translation in Mammalian Cells by Polysome Profiling
Published on: October 28, 2014
FTO blocks RNA translational activity via the loss of N6-methyladenosine methylation at 5' UTR regulated by RBM5 in
Liantao Li1,2, Debao Qu1,2, Bo Wang3
1The First School of Clinical Medicine, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Abstract:
N6-methyladenosine (m6A) methylation has been widely regarded in numerous biological functions including CR. Nonetheless, the molecular process of m6A methylation behind CR in non-small cell lung cancer (NSCLC) has no apparent significance. We identified in this study that the expression of FTO alpha-ketoglutarate dependent dioxygenase (FTO) was downregulated in CR NSCLC tissues and cells in vivo and in vitro. Additionally, RIP-seq indicated that loss of FTO contributed to the elevated m6A methylation at 5'-untranslated region of RNAs which were closely connected with tumor resistance and malignancy, and FTO exerted to exclude the recruitment of eIF3A to these target genes in CR NSCLC. Moreover, FTO-enriched transcripts displayed a reduced translational capability in CR NSCLC compared to the regular NSCLC cells. Finally, we also identified RNA binding motif protein 5 (RBM5) that could specially interact with FTO in regular NSCLC compared to CR NSCLC. Deficiency of RBM5 resulted in the abnormal recognition of transcripts by FTO, and led to the translation silencing of genes associated with CR such as ATP7A, ERCC1, CD99, CDKN3, XRCC5, and NOL3. Taken together, our data characterized FTO as a novel translation regulator and revealed the molecular mechanism on gene translation through the synergistic effects with RBM5 and m6A methylation in CR NSCLC cells.
Insights
FTO alpha-ketoglutarate dependent dioxygenase (FTO) downregulation in non-small cell lung cancer (NSCLC) promotes tumor resistance. FTO regulates gene translation via m6A methylation, impacting cancer progression.
Area of Science:
- Molecular Biology
- Oncology
- Epigenetics
Background:
- N6-methyladenosine (m6A) methylation plays roles in biological functions.
- The role of m6A methylation in chemoresistance (CR) of non-small cell lung cancer (NSCLC) remains unclear.
Purpose of the Study:
- To investigate the molecular mechanism of m6A methylation in chemoresistant NSCLC.
- To identify key regulators involved in this process.
Main Methods:
- Analysis of FTO expression in CR NSCLC tissues and cells.
- RNA immunoprecipitation sequencing (RIP-seq) to assess m6A methylation.
- Investigation of FTO's interaction with eIF3A and RBM5.
- Assessment of RNA-binding motif protein 5 (RBM5) role in FTO function.
Main Results:
- FTO expression was downregulated in CR NSCLC.
- Loss of FTO increased m6A methylation in 5'-untranslated regions, enhancing tumor resistance and malignancy.
- FTO inhibited eIF3A recruitment to target genes, reducing their translation.
- RBM5 deficiency impaired FTO's transcript recognition, leading to translation silencing of CR-associated genes.
Conclusions:
- FTO acts as a novel translation regulator in CR NSCLC.
- FTO's mechanism involves synergistic effects with RBM5 and m6A methylation.
- Understanding this pathway offers potential therapeutic targets for chemoresistant NSCLC.
Related Concept Videos
RNA Stability
Experimental RNAi
Regulation of Expression at Multiple Steps
MicroRNAs
Types of RNA
RNA Performs Diverse...
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

